Find News

Filter articles

Applied Filters

Showing 1 to 10 of 1869 results

Brazil Supreme Court suspends drug patent extensions

Brazil08-04-2021Alex Baldwin

Brazil’s highest court has suspended extensions of drug patents due to the public health emergency caused by COVID-19.

UK govt’s £20m fund for life sciences opens for applications

UK08-04-2021Muireann Bolger

The UK government’s £20 million fund aimed at growing life sciences manufacturing is now open for applications, it confirmed today, April 7.

AbbVie, Abbott fight bid to force FTC discovery disclosure

US06-04-2021Muireann Bolger

Pharmaceutical companies defending an antitrust lawsuit have fought back against attempts to get them to disclose confidential information garnered through discovery during the litigation to the US Federal Trade Commission.

US govt doesn’t have remdesivir patent rights, says GAO

US01-04-2021Legal developmentsMuireann Bolger

The US government doesn't co-own patents covering Gilead Science’s drug remdesivir, according to a report by the Government Accountability Office.

WHO urges vigilance against fake COVID-19 vaccines

29-03-2021Rory O'Neill

The World Health Organization has warned the public of the danger of counterfeit COVID-19 vaccines and urged people not to procure jabs outside of government channels.

Supreme Court denies MS treatment patent petition

US25-03-2021Alex Baldwin

The US Supreme Court has denied a petition from Argentum Pharmaceuticals to review a Federal Circuit ruling covering a multiple sclerosis treatment patent.

Genevant signs $600m liver fibrosis deal with Takeda

Canada18-03-2021Alex Baldwin

Genevant Sciences has entered into a licence agreement for Takeda to develop and market a new liver fibrosis treatment.

Biogen sues Teva over MS generic

US18-03-2021Muireann Bolger

A proposed Teva Pharmaceutical generic drug to treat multiple sclerosis infringes patents relating to Vumerity, according to a lawsuit filed by Biogen and Alkermes.

FTC launches pharma merger analysis group

US18-03-2021Alex Baldwin

The Federal Trade Commission (FTC) is launching a new international working group in an “imperative” move to better analyse the impact of pharmaceutical mergers.

NCAA targets ‘Vasectomy Mayhem’ trademark

US16-03-2021Alex Baldwin

The National Collegiate Athletic Association has filed a petition to cancel a urology centre's ‘Vasectomy Mayhem’ trademark ahead of the NCAA’s March Madness Basketball Tournament.

Showing 1 to 10 of 1869 results